Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
about
A Critical Appraisal of Solubility Enhancement Techniques of PolyphenolsA simple RP-HPLC method for the simultaneous determination of curcumin and its prodrug, curcumin didecanoate, in rat plasma and the application to pharmacokinetic study.Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia.A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomesDesign and evaluation of a self-microemulsifying drug delivery system for apigenin.Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility.Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.Free Radical Scavenging Activity: Antiproliferative and Proteomics Analyses of the Differential Expression of Apoptotic Proteins in MCF-7 Cells Treated with Acetone Leaf Extract of Diospyros lycioides (Ebenaceae).Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion.Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in miceCharacterization and evaluation of a self-microemulsifying drug delivery system containing tectorigenin, an isoflavone with low aqueous solubility and poor permeability.Systematic and comprehensive investigation of the toxicity of curcuminoid‑essential oil complex: A bioavailable turmeric formulation.Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcuminCurcumin nanomedicine: a road to cancer therapeuticsFluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in miceMechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Challenges associated with curcumin therapy in Alzheimer disease.Advances in nanotechnology-based delivery systems for curcumin.Nanocarriers for oral drug delivery.Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies.Preparation, characterization and bioavailability by oral administration of O/W curcumin nanoemulsions stabilized with lysophosphatidylcholine.A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.Oral bioavailability of curcumin: problems and advancements.Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.Modern drug delivery strategies applied to natural active compounds.Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells.Development and characterization of lutein-loaded SNEDDS for enhanced absorption in Caco-2 cells.Design of Organic Macrocycle-Modified Iron Oxide Nanoparticles for Drug Delivery.Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells.Preparation and characterization of intravenously injectable curcumin nanosuspension.Preparation and bioavailability assessment of SMEDDS containing valsartan.Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).Development, characterization and permeability assessment based on caco-2 monolayers of self-microemulsifying floating tablets of tetrahydrocurcuminDeveloping micro-/nanoparticulate drug delivery systems using "design of experiments".Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.
P2860
Q26852410-DC3C18BB-7032-4882-88E4-F725EBD1658DQ33811833-DB8F8EAB-631B-400B-9FA6-84E01A4644C1Q34060487-28609656-1875-4D83-BA84-B8606BC50D31Q34122290-A265C46B-D96C-4A84-A6B8-035890F5DB79Q34274270-BB311A7F-37DD-42F2-836B-665C2F564D2FQ34554669-94362CF4-CC39-4A89-B421-ECE797C2A7EAQ34956330-835F90BD-8BC2-4436-8DC6-AD7E5FFD0486Q35771256-AB53281F-247D-4FCA-9E46-2F35ED136F1EQ35803167-F16DD2AC-03FE-4C8D-BF51-7D250F2AF339Q35821890-C7CA9A84-ED68-4915-9645-C1AFD75CBAB4Q36011080-BB670438-31E3-4CA7-88C6-40ABE72F95E2Q36304680-BDE69722-AFA3-4809-BF1E-914040DEF748Q36390338-D7D37FD3-7AC2-4115-AD6F-BBD3A9194355Q36458029-4BE5FAD3-E0B1-436E-B096-EA134C95BBD1Q36807261-605B24AF-A354-4E55-AFF6-ED7C026440DCQ37138897-9FFF69A1-F291-467E-A72F-A2D44241A474Q37336117-8BAD4952-8A26-4330-A878-2BC372F8F4CCQ37693751-285B6B32-29B9-4BA1-A12F-C8EE93204C9CQ37702234-8BBE96FB-4AEE-4C31-9190-A67DB6BA76E2Q37740126-2D6ABE55-3AD1-4216-B8E6-7A924C670B79Q37805592-4E95153C-160C-4815-8915-2039E5A6E4D0Q37952439-665367D6-1FB1-40CF-95A4-DCEE3746864FQ38030643-A812C5C6-73F5-4FE6-8E8D-C245A64C3DFFQ38101960-AEDFC1D7-1311-46B7-A1CF-6B090DA10300Q38257856-D9111AA9-4EBC-4051-ACBE-A7D61B4B69E8Q38601227-3E1E15BD-250E-41B8-B897-48431A82115BQ38744748-56A0DBF0-5AEF-4AF6-9478-131F3ABFB9FEQ38760621-46E43639-E14D-4236-AE2F-A24E70226A12Q38910964-6A15BB6F-97AB-445C-880E-82478D5B7DBDQ38949215-794A54AD-FF3D-46C4-BE81-95F0F2CEB1FFQ38995220-AA00D7CF-57EA-4A60-B448-14C83C7ACF8EQ39103783-BE144516-191B-4D75-BBEB-4EAEF05DDB9DQ39121482-CCB028AB-0BC9-403B-82DB-A2238DF66210Q39626074-B6EFA8F8-ABBA-46B9-9D96-0F3C7EA4E1DFQ39645325-CA471B37-9E33-438B-B58C-2F6C3970A9C6Q39922643-996B8065-7493-4307-93B8-4117B4A5D0A1Q40728869-F71881E8-282C-4C3B-86FD-1B3EABF66D9AQ41988058-5B28E710-CE1F-4AF6-8730-0795696F74C6Q42098613-EAC585CE-6FCB-4636-BB9E-05BD0B29CADFQ42223300-4DF744C1-66E3-4A1B-AB58-F11855B9FDC3
P2860
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Enhancement of oral absorption ...... sifying drug delivery systems.
@ast
Enhancement of oral absorption ...... sifying drug delivery systems.
@en
Enhancement of oral absorption ...... sifying drug delivery systems.
@nl
type
label
Enhancement of oral absorption ...... sifying drug delivery systems.
@ast
Enhancement of oral absorption ...... sifying drug delivery systems.
@en
Enhancement of oral absorption ...... sifying drug delivery systems.
@nl
prefLabel
Enhancement of oral absorption ...... sifying drug delivery systems.
@ast
Enhancement of oral absorption ...... sifying drug delivery systems.
@en
Enhancement of oral absorption ...... sifying drug delivery systems.
@nl
P2093
P1476
Enhancement of oral absorption ...... sifying drug delivery systems.
@en
P2093
Guangxi Zhai
Hongxiang Lou
Weiwei Zhu
P304
P356
10.1016/J.IJPHARM.2008.12.009
P407
P577
2008-12-13T00:00:00Z